Point of care testing supports patients to receive timely respiratory care in the community

Point of care testing supports patients to receive timely respiratory care in the community

A new evaluation of the GP Urgent Assessment Service (GPUAS) pilot in South Somerset has shown that point of care testing (POCT), when used alongside clinical judgement and rapid diagnostics, can support diagnosis and treatment of patients with non-life-threatening conditions, to prevent escalation of illness and hospital referrals.

Between January and May 2024, Symphony Healthcare Services (SHS) piloted the GPUAS within the South Somerset West Primary Care Network, providing rapid assessment, enhanced diagnostics, therapeutic capabilities and short-term observation. During this 19-week period, 1,481 referrals were made to the GPUAS for 1,351 patients.

Patients were offered diagnostic testing, treatment, minor surgical procedures, periods of observation, referral for further testing, advice and reassurance dependent on their needs.

Health Innovation South West evaluated the GPUAS to learn how the service can best support patients with urgent needs within the community and the impact it has on them and the system, to help with further development of the service. The evaluation also examined the acceptability and impact of introducing POCT within this community-based model.

 

Using point of care testing (POCT)

POCT can quickly provide additional information to support clinical decision-making in cases of diagnostic uncertainty without the need to send samples to a pathology laboratory, which may take several days before results are analysed and returned.

The timely and clinically guided use of POCTs may therefore enhance the effectiveness of primary care-based urgent care models in managing patient demand, improving care coordination, and facilitating rapid assessment and treatment.

Three different POCT machines were used by the GPUAS: The Siemens EPOC; the LumiraDx (recently purchased by Roche); and the Abbott ID NOW, with 232 patients receiving at least one of these tests.

The most common presenting symptoms in patients seen through the service were coughs, dyspnoea (difficulty breathing), abdominal pain, chest pain and sore throat.

Respiratory diseases account for many consultations and antibiotic prescriptions in primary care. A significant portion of these diseases is viral, for which antibiotics are ineffective. The UK Health Security Agency reported an increase in invasive group A streptococcus diseases in 2022, exacerbating NHS pressures. Enhanced diagnostics like POCT can help manage respiratory diseases more effectively within primary care, reducing unnecessary antibiotic prescriptions and Emergency Department visits.

Given this demand on the health system, Abbott supplied the GPUAS with POCT for common respiratory pathogens, including Group A Streptococcus, Influenza A and B and COVID.

Gabrielle Du Toit, Regional General Manager, Infectious Diseases, UK, Ireland and Nordics said: “Abbott is proud to work in partnership with Symphony Healthcare and Health Innovation South West. The GPUAS has demonstrated that the addition of molecular point of care testing supports the patient pathway, enabling patients to obtain the right diagnosis at the right time at point of need.

Having access to an accurate diagnostic along with clinical history taking underpins the wider issue with appropriate antimicrobial stewardship. This evaluation further supports the case for community-based settings closer to home, reducing footfall and burden within secondary care settings.”

Dr Berge Balian, GP at Crewkerne Health Centre and Medical Director at Symphony Healthcare Services Ltd added: “Having already trialled Point of Care Testing (POCT) in one of our practices for some time, Symphony Healthcare Services was delighted to have the opportunity to utilise a comprehensive POCT package during the GPUAS pilot, with particular support from Abbot Diagnostics.

The Abbott ID NOW machine enabled testing for Streptococcus A, Influenza A and B, COVID, and respiratory syncytial virus (RSV). Our experience was that, whilst all these tests could be helpful in aiding diagnosis, the most useful was the Strep A test, which not only provided confidence to patients and clinicians regarding the diagnosis of Scarlet Fever but was also helpful in limiting inappropriate antibiotic prescribing for patients testing negative.

During the pilot, the LumiraDx machine enabled testing for D-Dimer, a clotting indicator helpful in supporting the diagnosis of venous thromboembolism (VTE) and CRP (an inflammatory marker helping to diagnose serious acute infections or inflammation), and INR (clotting level). D-Dimer testing was particularly helpful in reducing the number of patients referred to hospital, whilst CRP testing was helpful in supporting the decision as to which unwell patients could safely be managed at home and which required hospital admission.

The Siemens EPOC machine evaluated electrolytes, lactate, and blood gases. Our conclusion was that these tests were of limited value in the Primary Care setting, as most patients for which these tests are indicated should be managed in a hospital setting.

In sum, Point of Care Testing, particularly Strep. A, D-Dimer and CRP analysis, has the potential to radically improve the accuracy of diagnosis and effective management of medical conditions in General Practice.”

 

Key findings

The impact of POCT on patients

A total of 125 (8% of GPUAS) patients were tested with at least one of the Abbott ID NOW tests with 43 (34%) positive tests confirming diagnosis and 82 negative tests, ruling out strep A, COVID or flu.

Patients who had a respiratory POCT were asked to complete a survey about their experience of being tested, with 99% of respondents feeling positive or very positive. 99% also reported high levels of understanding about what they were being tested for, 95% had trust in the test result, and 99% were glad to have an immediate result and felt that it was a worthwhile thing to do.

49% of respondents felt that having the POCT enabled their clinician to make appropriate decisions about their care and 32% were reassured by their test result, with 21% feeling that they avoided the anxiety of waiting for their result.

One patient commented: “Very quick and easy. Extremely valuable to have the results back so quickly.”

 

The impact of POCT on clinicians and clinical management behaviours

GPUAS staff were very positive about the benefits of having access to POCT for respiratory infection. They emphasised the importance of testing when a bacterial infection is suspected, as the result directly influences critical management decisions, such as prescribing antibiotics. 

The test for strep A was reported to be used most frequently and was cited as being the most useful test. However, there were some significant benefits from also having the flu test, in terms of speeding up access to treatment. 

 At the point of testing patients with the Abbott ID NOW tests, clinicians were asked to fill out a form that asked them: “In your professional opinion, if you did not have access to the ID NOW point of care testing, based on what you currently know about the patient: what would your next course of action be?”

In 46% (57 of 125) of cases, clinicians offered a different course of action following the test, suggesting that the test results (whether positive or negative) influenced the treatment plan for patients even when the clinician had a thorough history and clinical understanding of the presenting issues. 

 Staff at the GPUAS felt there were three main benefits of POCT:

  1. Where POCT showed a negative result, as it prevented unnecessary use of antibiotics, and could be used to reassure patients that medication was not necessary. This helped clinicians manage the conversation with patients who were anxious, or who had an expectation of receiving antibiotics, as they had received them in the past.
  2. There were instances where POCT picked up infection that was not apparent to the clinician and enabled rapid treatment that may otherwise not have been put in place. Examples were given of how this can have powerful positive consequences for seriously ill patients, such as one who needed hospitalisation, and was able to receive immediate medication due to the POCT that had been carried out, without needing to wait for further in-hospital assessment.
  3. In the other cases where POCT confirmed clinician’s judgement, this was also felt to be helpful, as it supported confidence in the proposed care plan.

GPUAS staff and stakeholders felt there was a place for POCT in primary care to support clinical decision-making and conversations with patients regarding not prescribing antibiotics. It was viewed that positive or negative results from POCT can support people to remain out of hospital, or to be more quickly and effectively treated in hospital, with the results from the test informing care.

One referring GP practice noted: “Utilised point of care testing and able therefore to treat and discharge patients safely without the need for secondary care input.”

 

Summary of service

In 19 weeks, the GPUAS was able to establish itself as a safe alternative referral route for patients with an urgent care need in the community. Referrers felt confident that the GPUAS could provide timely and accurate diagnosis for urgent patients.

Point of care testing was felt to be vital in supporting the likely reduction in acute admissions and referrals to secondary care and preventing escalation of illness in patients being seen by the service.

You can read the full evaluation of the GPUAS here.

You may also be Interested in

Driving rural and coastal health innovation: Our Impact Report 2025-26

Driving rural and coastal health innovation: Our Impact Report 2025-26

Read more
National report highlights role of South West perinatal innovation in improving care for premature babies

National report highlights role of South West perinatal innovation in improving care for premature babies

Read more
Ensuring the national ambition for neighbourhood health reflects the rural communities it will serve

Ensuring the national ambition for neighbourhood health reflects the rural communities it will serve

Read more
National audit highlights strong outcomes for premature babies across South West England

National audit highlights strong outcomes for premature babies across South West England

Read more
Newsletter

Stay up to date

Sign up to hear more from us

Back to top